Literature DB >> 22046097

Hypergastrinemia and recurrent type 1 gastric carcinoid in a young Indian male: necessity for antrectomy?

Viplove Senadhi1, Niraj Jani.   

Abstract

Carcinoid tumors are the most common neuroendocrine tumors. Gastric carcinoids represent 2% of all carcinoids and 1% of all gastric masses. Due to the widespread use of Esophagogastroduodenoscopy for evaluating a variety of upper gastrointestinal symptoms, the detection of early gastric carcinoids has increased. We highlight an alternative management of a young patient with recurrent type 1 gastric carcinoids with greater than 5 lesions, as well as lesions intermittently greater than 1 cm. Gastric carcinoids have a variable presentation and clinical course that is highly dependent on type. Type 1 gastric carcinoids are usually indolent and have a metastasis rate of less than 2%, even with tumors larger than 2 cm. There are a number of experts as well as organizations that recommend endoscopic resection for all type 1 gastric carcinoid lesions less than 1 cm, with a follow-up every 6-12 mo. They also recommend antrectomy for type 1 gastric carcinoids with greater than 5 lesions, lesions 1 cm or greater, or refractory anemia. However, the American Society of Gastrointestinal Endoscopy guidelines state that type 1 gastric carcinoid surveillance is controversial based on the evidence and could not make an evidence-based position statement on the best treatment modality. Our report illustrates a rare cause of iron deficiency anemia in a young male (without any medical history) due to multiple recurrent gastric carcinoid type 1 lesions in the setting of atrophic gastritis causing hypergastrinemia, and in the absence of a vitamin B12 deficiency. Gastric carcinoid type 1 can present in young males without an autoimmune history, despite the known predilection for women aged 50 to 70 years. Type 1 gastric carcinoids can be managed by endoscopic resection in patients with greater than 5 lesions, even with lesions larger than 1 cm. This course of treatment enabled the avoidance of early antrectomy in our patient, who expressed a preference against more invasive measures at his young age.

Entities:  

Keywords:  Antrectomy; Endoscopic resection; Gastric carcinoid; Hypergastrinemia; Iron deficiency anemia

Mesh:

Substances:

Year:  2011        PMID: 22046097      PMCID: PMC3199567          DOI: 10.3748/wjg.v17.i35.4052

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

1.  Treatment of solitary gastric carcinoid tumor by endoscopic polypectomy in a patient with pernicious anemia.

Authors:  Gurhan Kadikoylu; Irfan Yavasoglu; Vahit Yukselen; Esra Ozkara; Zahit Bolaman
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

2.  Hypergastrinemia in rheumatoid arthritis is related to Sjögren's syndrome.

Authors:  P Netter; G Faure; A Brassine; A Gaucher; P Franchimont
Journal:  J Rheumatol       Date:  1985-06       Impact factor: 4.666

3.  Fasting plasma-gastrin in vitiligo.

Authors:  E T Okosdinossian; H A Munshid; A I Wasfi; M A Ahmed; R C Russell; M Hobsley
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

4.  Carcinoid tumors of the stomach: a clinical and radiographic study.

Authors:  A J Binstock; C D Johnson; D H Stephens; R V Lloyd; J G Fletcher
Journal:  AJR Am J Roentgenol       Date:  2001-04       Impact factor: 3.959

5.  Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.

Authors:  Kurt Borch; Bo Ahrén; Håkan Ahlman; Sture Falkmer; Göran Granérus; Lars Grimelius
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

6.  Carcinoid tumors. An analysis of 2,837 cases.

Authors:  J D Godwin
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

7.  Hypergastrinaemia in chronic renal failure.

Authors:  M G Korman; M C Laver; J Hansky
Journal:  Br Med J       Date:  1972-01-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.